Nuclea Biotechnologies Receives $5,000,000 Series C Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=be44b491-82b9-432f-bd94-e00dd742caa4&Preview=1
Date
8/2/2012
Company Name
Nuclea Biotechnologies
Mailing Address
105 South Street Pittsfield, MA 01201
Company Description
Nuclea Biotechnologies’ primary mission is to conduct genomic research in the oncology field so as to discover biomarkers and gene or protein expression profiles that are unique to oncologic diseases.
Website
http://www.nucleabiomarkers.com
Transaction Type
Venture Equity
Transaction Amount
$5,000,000
Transaction Round
Series C
Proceeds Purposes
The company will use the proceeds to support clinical trials and new hires related to the development of its fatty acid synthase tests for prostate and breast cancers.
M&A Terms
Venture Investor
Undisclosed